Inactive

NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Acquisition of Microwave Synthesis Vials and Low Volume Recovery Vials (i) This is a combined synopsis/solicitation for commercial products and ... NON-COMPETITIVE COMBINED SYNOPSIS / SOLICITATION Title: Acquisition of Microwave Synthesis Vials and Low Volume Recovery Vials (i) This is a combined synopsis/solicitation for commercial products and commercial services prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95025Q00151 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial product or commercial service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Products and Commercial Services, and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to: TWD TradeWinds. Inc, 10555 86th Avenue Pleasant Prairie, WI 53158 for the Acquisition of Microwave Synthesis Vials and Low Volume Recovery Vials. This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-1(b)(1). The rationale for a sole source is the location of the facility and use of REES alarm monitoring system which is also used by NCATS on-site. The freezers and frozen samples are already on-site at the Kamtek facility and the risk of moving sites increases the likelihood of damaging samples which presents an unmeasurable cost in regard to the impact the loss of valuable scientific data. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2025-03, with effective date January 17, 2025. (iv) The associated NAICS code is 334516- Analytical Laboratory Instrument Manufacturing and the small business size standard is 1,000 employees. (v) This requirement is for the following product: Acquisition of Microwave Synthesis Vials and Low Volume Recovery Vials. Please see the attached Purchase Description (PD) for detailed requirements. (vi) The National Center for Advancing Translational Sciences (NCATS) is in the need to acquire: MRVs- Microwave Synthesis Vials and HRVs- Low Volume Recovery Vials. Background Information: Microwave Reaction Vials (MRVs) are specifically designed to withstand the extreme conditions of microwave-assisted reactions. These vials are made from materials that can endure high temperatures and pressures generated during rapid heating processes. They are commonly used in laboratories for accelerating chemical reactions in applications such as synthesis, digestion, and extraction. The use of microwave heating improves reaction efficiency by providing uniform and precise temperature control. High Recovery Vials (HRVs) are laboratory vials specifically designed to minimize sample loss during storage and handling. Made from high-quality glass or specialized polymers, these vials prevent contamination and evaporation, which is particularly critical when dealing with small or valuable samples. HRVs are commonly used in analytical laboratories for applications that require precise measurements, such as chromatography, sample analysis, and biological research. (vii) The Government anticipates award of a firm fixed-price purchase order for this acquisition, and the anticipated delivery date is expected to be eight (8) weeks ARO. (viii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html https://www.acquisition.gov/caac-letters (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (Nov 2024) 52.204-8, Annual Representations and Certifications (JAN 2025) (DEVIATION FEB 2025) See CAAC_Letter_2025-01_Supplement-1.pdf and CAAC_Letter_2025-02_Supplement-1.pdf FAR 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020) FAR 52.204-29, Federal Acquisition Supply Chain Security Act Orders – Representation and Disclosures (Dec 2023) FAR 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services (Sep 2023) FAR 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (May 2024) (DEVIATION Feb 2025) CAAC_Letter_2025-01_Supplement-1.pdf and CAAC_Letter_2025-02_Supplement-1.pdf The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html https://www.acquisition.gov/caac-letters (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13, System for Award Management Maintenance (Oct 2018) FAR 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020) FAR 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services (Nov 2023). FAR 52.217-9, Option to Extend the Term of the Contract (Mar 2000). 3 years and 9 months HHSAR 352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) HHSAR 352.239-78, Information and Communication Technology Accessibility Notice (Feb 2024) (DEVIATION). HHSAR 352.239-79, Information and Communication Technology Accessibility Notice (Feb 2024) (DEVIATION). The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions below and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Nov 2021) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (Oct 2020) FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Products and Commercial Services (Jan 2025) (DEVIATION Feb 2025) Per CAAC Letters 2025-01 and 2025-02, FAR 52.222-21, Prohibition of Segregated Facilities and FAR 52.222-26 - Equal Opportunity will not be considered when making award decisions or enforce requirements. FAR 52.222-48 Exemption from Application of the Service Contract Labor Standards to Contracts for Maintenance, Calibration, or Repair of Certain Equipment-Certification (May 2014). FAR DEVIATION STATEMENT: The CAAC Letter 2025-01 -Supplement 1 and CAAC Letter 2025-02-Supplement 1 are applicable to this acquisition. System updates may lag policy updates. The System for Award Management (SAM) may continue to require entities to complete representations based on provisions that are not included in agency solicitations. Examples include 52.222-25, Affirmative Action Compliance, and paragraph (d) of 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services. Contracting officers will not consider these representations when making award decisions or enforce requirements. Entities are not required to, nor are they able to, update their entity registration to remove these representations in SAM. The mentioned CAAC Letters may be accessed electronically at this address: CAAC Letters | Acquisition.GOV. The following invoice instruction is included and will be incorporated in the final award: NIH Invoicing Instructions with IPP (Mar 2023). (ix) The provision at FAR clause 52.212-2, Evaluation-Commercial Products and Commercial Services (Nov 2021), applies to this acquisition. (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: (i) technical capability of the service offered to meet the Government requirement; (ii) past performance [see FAR 13.106-2(b)(3)]; and (iii) price. Technical and past performance, when combined, are significantly more important than price. (b) Options. The Government will evaluate offers for award purposes by adding the total price for all options to the total price for the basic requirement. The Government may determine that an offer is unacceptable if the option prices are significantly unbalanced. Evaluation of options shall not obligate the Government to exercise the option(s). (c) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (x) Offerors must include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services (May 2024) (DEVIATION Feb 2025), with its offer. If the offeror has completed FAR clause 52.212-3 at www.sam.gov, then the offeror does not need to provide a completed copy with its offer. See DEVIATION STATEMENT above regarding applicable CAAC Letters. (xi) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xii) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xiii) Responses to this solicitation must include clear and convincing evidence of the offeror’s capability of fulfilling the requirement as it relates to the technical evaluation criteria. The price proposal must include the labor categories, an estimate of the number of hours required for each labor category, fully loaded fixed hourly rate or each labor category, breakdown and rationale for other direct costs or materials, and the total amount. The Unique Entity ID from SAM.gov, the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations must be received by Thursday, April 3rd, 2025 at 11:00 am Eastern Daylight/Standard Time and reference Solicitation Number 75N95025Q00151. Responses must be submitted electronically to Nicholas Niefeld, Contracting Officer, at nick.niefeld@nih.gov Fax responses will not be accepted.

Inactive

Solicitation Number: 75N95025Q00151 Title: Acquisition of Microwave Synthesis Vials and Low Volume Recovery Vials Classification Code: 6640 NAICS Code: 541714 - Research and Development in Biotechnolo... Solicitation Number: 75N95025Q00151 Title: Acquisition of Microwave Synthesis Vials and Low Volume Recovery Vials Classification Code: 6640 NAICS Code: 541714 - Research and Development in Biotechnology (Except Nanobiotechnology) Dollars or Number of Employees: 1,000 employees Description: The purpose of this requisition is to procure Brand name or equal, MRVs is to facilitate controlled and uniform heating and , HRVs is to preserve the integrity and volume of precious samples, ensuring accurate analysis and reducing the risk of contamination. The National Institutes of Health (NIH) is the nation’s leading medical research agency and the primary Federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people’s health and save lives. The National Center for Advancing Translational Sciences (NCATS) is a part of the National Institutes of Health (NIH), whose mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. In doing so the collaborative team aims to develop a high-throughput chromatin assay. The reagent has been used in the optimization phase of the protocol and this purchase will provide material for high-throughput screening. Purpose and Objectives: Microwave Reaction Vials (MRVs) are specifically designed to withstand the extreme conditions of microwave-assisted reactions. These vials are made from materials that can endure high temperatures and pressures generated during rapid heating processes. They are commonly used in laboratories for accelerating chemical reactions in applications such as synthesis, digestion, and extraction. The use of microwave heating improves reaction efficiency by providing uniform and precise temperature control. Objective of Acquiring MRVs: The primary objective of acquiring MRVs is to improve the efficiency and speed of chemical reactions, ensuring uniform heating and faster completion of experiments. By utilizing MRVs, laboratories can reduce energy consumption and processing time while maintaining consistent reaction conditions, ultimately improving the overall productivity and reliability of experimental outcomes. High Recovery Vials (HRVs) High Recovery Vials (HRVs) are laboratory vials specifically designed to minimize sample loss during storage and handling. Made from high-quality glass or specialized polymers, these vials prevent contamination and evaporation, which is particularly critical when dealing with small or valuable samples. HRVs are commonly used in analytical laboratories for applications that require precise measurements, such as chromatography, sample analysis, and biological research. The objective of acquiring HRVs is to ensure minimal sample loss, which is vital for obtaining accurate results in experiments involving trace quantities of compounds. These vials help maintain sample integrity by preventing evaporation and contamination, thereby improving the accuracy of measurements and the reliability of experimental data. By acquiring HRVs, laboratories can improve their overall analytical processes and make the most of valuable or limited samples. Project requirements: Microwave Reaction vials (MRV) 2-5ml, caps, Stirrer bars and barcoding MRV-2-5ml-30x15&7mm-TARE-KIT-B. 2-5ml MICROWAVE REACTION KIT. KIT INCLUDES: 2-5ml CLEAR GLASS. ROUND BOTTOM MICROWAVE VIALS (QTY: 100), ALUMINUM CAPS WITH SEPTA (QTY:100) & MAGNETIC STIR BARS (QTY: 100). VIALS COME WITH permabond 30x15mm & 7mm CIRCLE MATCHING CERAMIC BARCODE/TEXT LABELS TO CUSTOMER SPECIFICATIONS ON SIDE & BOTTOM OF GLASS LABWARE. VIALS WILL BE TARE WEIGHED (WITHOUT CAPS) TO 4 DECIMAL PLACES. High recovery Vials (HRV)- 30ml, caps, stirrer bars and barcoding CLEAR GLASS 28x95mm HIGH RECOVERY VIALS WITH 24-400 GPI THREAD FINISH.VIALS COME WITH PermaBond 30x15mm & 7mm CIRCLE CERAMIC MATCHING BARCODED LABELS APPLIED ON SIDE AND BOTTOM OF VIAL TO CUSTOMER SPECIFICATION. VIALS WILL BE TARE WEIGHED. 24-400 BLACK CLOSED TOP PHENOLIC CAP WITH PTFE/14B RUBBER LINER. 200/CASE. S-SETUP-PermaBond ONE TIME SET-UP CHARGE FOR PermaBond LABELING PER LABWARE/BARCODE TYPE. Salient characteristics The characteristics at the minimum shall meet the following requirements: Both MRVs and HRVs Should have a. Caps b. Stirrer bars c. Tared wt d. Barcoded Quantity Requested MRVs 2-5ml- qty-1000 HRVs 30ml-qty- 500 Anticipated Delivery Date: Anticipated to be delivered approximately 8 weeks from receipt of PO. Place of Delivery: The place of delivery shall be: 9800 Medical Center Dr Bldg B Rockville, MD 20850 Other important considerations: Independently and not as an agent of the Government, the Contractor shall furnish all the necessary services, qualified personnel, material, equipment, and facilities, not otherwise provided by the Government as needed to perform the work mentioned above. Capability statement /information sought. Respondents must provide clear and convincing documentation of their capability of providing the services specified in this notice. Also, information must be provided in sufficient details of the respondents’ (a) staff expertise, including their availability, experience, formal and other training; (b) current in-house capability to perform the work; (c) prior completed projects of similar nature; (d) corporate experience and other management capability; and (e) examples of prior completed Government contracts, references, and other related information. The respondent must also provide their DUNS number, organization name, address, point of contact, and size and type of business (e.g., 8(a), HubZone, etc., pursuant to the applicable NAICS code and any other information that may be helpful in developing or finalizing the acquisition requirements. One (1) copy of the response is required and must be in Microsoft Word or Adobe PDF format using 11-point or 12-point font, 8-1/2” x 11” paper size, with 1” top, bottom, left and right margins, and with single or double spacing. The information submitted must be in and outline format that addresses each of the elements of the project requirement and in the capability statement /information sought paragraphs stated herein. A cover page and an executive summary may be included but is not required. The response is limited to ten (10) page limit. The 10-page limit does not include the cover page, executive summary, or references, if requested. The response must include the respondents’ technical and administrative points of contact, including names, titles, addresses, telephone and fax numbers, and e-mail addresses. All responses to this notice must be submitted electronically to the Contract Specialist and Contracting Officer. Facsimile responses are NOT accepted. The response must be submitted to Nick Niefeld, Contract Specialist at e-mail address nick.niefeld@nih.gov. The response must be received on or before March 27, 2025, at 3 pm Eastern Time. “Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a presolicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).”